r/valueinvesting
I am looking to diversify into food stocks and i am looking at ADM and BG
Author compares ADM as a defensive, dividend-growth play with BG as a higher-risk, higher-growth play post-Viterra acquisition.
- ADM provides defensive diversification and a 53-year dividend growth track record
- BG offers impressive revenue growth and global supply chain optionality via Viterra
- ADM's nutrition segment may drag margins when grain trading is booming
- BG's significant debt leverage from the Viterra acquisition poses a major risk
ADM - Feels like the more defensive pick. They have a broader scope with their nutrition and specialty ingredients segments, which provides a nice hedge against pure commodity volatility. The dividend consistency (53 years of growth) is a major draw, but their recent EPS guidance of $4.15–$4.70 seems to be priced for a very steady, non-explosive environment. ADM is sensitive to U.S. Renewable Fuels Standard (RVO) and ADM has a strong position in ethanol and renewable diesel. ADM’s nutrition segment sometimes acts as a drag on margins when the grain-trading business is booming.
BG - Seems like the growth/risk play. The Viterra integration is clearly the main event here. The revenue growth is impressive, but the leverage they took on to make it happen makes me a bit cautious. The Viterra debt load is definitely the elephant in the room, Bunge took on significant debt to close the deal. The core argument for the Viterra deal is "optionality" the ability to shift grain flows more efficiently across the globe.
Both operate on a global scale and both have a dividend of around 2.5%. What are you your thoughts about ADM and BG in relation to value and what are your thoughts of the food industry in general?
Interesting ideas for diversifying into the food sector. I'd recommend stress-testing the fundementals of each business before committing.
Agricultural processors are structurally challenging from a quality investing standpoint, with thin margins, high capital intensity, and earnings that are heavily tied to commodity cycles and crush spreads rather than pricing power. Single-digit margins make it difficult to consider as a long-term compounder.
ADM's dividend payments have been growing for more than 3 decades, which is impressive, but it's worth checking whether it's been funded by genuine earnings growth, possible debt combination or an increase in the payout ratio. If free cashflow has been consistently reported below earnings that would be a yellow flag on dividend sustainability. Worth noting that a 30+ year dividend payment is hard to ignore. Had you invested in ADM that long ago you'd have almost recouped your investment and basically be playing with house money at this point.
On Bunge specifically, the debt taken on for Viterra is the right thing to be cautious about. Net Debt/EBITDA post-acquisition is the number I'd track closely — if it's above 2.5x and not deleveraging as quickly as possible, that limits the returns regardless of how good the strategic rationale may be.
Both businesses survive and probably grow — but "survive and grow" isn't the same as "compound capital at above-average rates" . Diving deeper into the numbers would it clear on what to consider and what to avoid.
Building on what others said about thin margins, I think the ADM-vs-BG framing might be the wrong question. Both are price-takers on a crush spread, so neither really has the pricing power that makes something compound. Picking between them isn't picking the better compounder, it's picking which risk you'd rather hold.
With ADM you're holding the accounting question someone flagged above. The nutrition segment was supposed to be the margin hedge, and it's the exact part that drew the SEC inquiry, so your reason to prefer ADM and your biggest risk in ADM are the same segment. With BG you're holding execution and leverage risk on Viterra, which is at least a cleaner, more trackable risk: Net Debt/EBITDA either comes down on schedule or it doesn't, and you'll see it quarter by quarter.
So I'd reframe it. If you want a defensive sleeve, an unresolved accounting overhang isn't defensive no matter how steady the dividend looks. If you're underwriting the Viterra deleveraging and you think the optionality is real, BG is a definable bet with a number you can watch. But "diversify into food" as a goal worries me a bit. These are commodity processors, not consumer-staples compounders. The dividend longevity is real, but a 50-year payout funded by a low-margin, cyclical, capital-hungry business is a different animal than the staples people usually mean when they say defensive.
how about pizza ?
The nutrition segment you like as a hedge is the same part of ADM that ran into accounting trouble. In early 2024 the company put its CFO on leave, delayed its earnings, and disclosed an SEC investigation into how it priced sales between its own divisions inside that business, and the stock fell about 24 percent in a single day. So if nutrition is your reason to pick ADM over a plain grain trader, I would read those segment results closely now that the review has wrapped before I trusted it as a hedge. On Bunge I would watch how fast they pay the Viterra debt down compared to their profits, since the deal only works if they bring that load back down on schedule rather than carrying it for years.
Do yourself a favor and just buy gold instead or VXUS or voo -hell maybe btc. Don’t “diversify” for its own sake.
Did ADM ever fix their accounting irregularities?